Harte-Hanks (NASDAQ: HHS) reported Q3 EPS of $0.08, $0.10 worse than the analyst estimate of $0.18. Revenue for the quarter came in at $47.12 million versus the consensus estimate of $47.7 million.

For earnings history and earnings-related data on Harte-Hanks (HHS) click here.